Mylan to launch cheaper EpiPen after political backlash

By Robert King

Published August 29, 2016 2:50pm ET

Add Washington Examiner on Google

Mylan to launch cheaper EpiPen after political backlash — Eight-page letter shows much skepticism over Mylan's move to sell a cheaper version of the allergy shot. (AP Photo/Rich Pedroncelli, File) | Rich Pedroncelli

Mylan is taking another stab at trying to quell the outrage over its $600 price tag for the life-saving allergy treatment EpiPen.

The generic drug company said it will sell a cheaper version of the EpiPen that will cost $300 for a two-pack carton, a 50 percent discount. Mylan’s price increase on EpiPen has sparked calls from Congress for hearings. Mylan said it will release the new product in the next few weeks.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Minusextra Pharmaceutical Industry Richard Blumenthal Robert King